Allergen

Allergen identifies any substance capable of triggering allergic reactions through immune system activation, causing symptoms ranging from mild irritation to life-threatening anaphylaxis. In pharmaceutical contexts, allergens encompass ingredients, excipients, manufacturing residuals, or host cell proteins that provoke hypersensitivity responses in susceptible individuals. Common pharmaceutical allergens include egg proteins in viral vaccines, latex in packaging components, and residual antibiotics used during production processes.

The biopharmaceutical industry maintains rigorous allergen management programmes throughout product development and manufacturing to protect patient safety and ensure regulatory compliance. Manufacturers must identify potential allergens in raw materials, document their presence in master formulas, and implement controls that prevent cross-contamination during production. Labelling requirements mandate clear allergen declarations, enabling healthcare providers and patients to make informed treatment decisions. For therapeutic proteins produced in mammalian, bacterial, or insect cell systems, host cell proteins represent critical process-related impurities requiring careful characterisation and removal through validated purification processes. Biosimilar developers must demonstrate comparable allergenicity profiles to reference biologics through comprehensive analytical and clinical testing. As gene therapies and novel vaccine platforms emerge utilising diverse expression systems, allergen risk assessment becomes increasingly complex, demanding sophisticated analytical methods to detect, quantify, and mitigate allergenic components while maintaining product efficacy and ensuring patient access to transformative therapies.